Swiss National Bank’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$6.81M	Buy	65,200 +4,200	+7%	+$438K	﹤0.01%	1119
2025 Q1	$7.11M	Sell	61,000 -400	-0.7%	-$46.7K	0.01%	1064
2024 Q4	$5.2M	Buy	61,400 +900	+1%	+$76.1K	﹤0.01%	1312
2024 Q3	$5.44M	Hold	60,500	–	–	﹤0.01%	1278
2024 Q2	$4.87M	Hold	60,500	–	–	﹤0.01%	1300
2024 Q1	$4.83M	Hold	60,500	–	–	﹤0.01%	1325
2023 Q4	$4.82M	Sell	60,500 -11,200	-16%	-$891K	﹤0.01%	1313
2023 Q3	$5.01M	Sell	71,700 -4,100	-5%	-$287K	﹤0.01%	1274
2023 Q2	$5.45M	Buy	75,800 +5,500	+8%	+$395K	﹤0.01%	1265
2023 Q1	$4.34M	Sell	70,300 -2,700	-4%	-$167K	﹤0.01%	1366
2022 Q4	$5.63M	Buy	73,000 +3,800	+5%	+$293K	﹤0.01%	1245
2022 Q3	$3.09M	Buy	69,200 +2,600	+4%	+$116K	﹤0.01%	1578
2022 Q2	$2.55M	Buy	66,600 +8,600	+15%	+$329K	﹤0.01%	1746
2022 Q1	$2.4M	Buy	58,000 +4,500	+8%	+$186K	﹤0.01%	1928
2021 Q4	$2.02M	Hold	53,500	–	–	﹤0.01%	2053
2021 Q3	$1.76M	Hold	53,500	–	–	﹤0.01%	2134
2021 Q2	$3.61M	Sell	53,500 -10,500	-16%	-$708K	﹤0.01%	1722
2021 Q1	$3.62M	Buy	64,000 +800	+1%	+$45.3K	﹤0.01%	1657
2020 Q4	$5.15M	Buy	63,200 +200	+0.3%	+$16.3K	﹤0.01%	1358
2020 Q3	$4.49M	Buy	63,000 +1,100	+2%	+$78.4K	﹤0.01%	1241
2020 Q2	$5.09M	Buy	61,900 +15,100	+32%	+$1.24M	﹤0.01%	1140
2020 Q1	$2.75M	Buy	46,800 +700	+2%	+$41.2K	﹤0.01%	1254
2019 Q4	$4.77M	Buy	46,100 +2,800	+6%	+$289K	﹤0.01%	1180
2019 Q3	$876K	Hold	43,300	–	–	﹤0.01%	2120
2019 Q2	$1.12M	Buy	+43,300	New	+$1.12M	﹤0.01%	2057